There are no coupons available for Incruse. Incruse Ellipta is a prescription medication used to treat chronic obstructive pulmonary disease (COPD) [1].
What is Incruse Ellipta?
Incruse Ellipta is a long-acting muscarinic antagonist (LAMA) medication containing the active ingredient umeclidinium [1]. It is delivered via an inhaler and works by relaxing the muscles around the airways in the lungs, making it easier to breathe [1]. It is prescribed to help manage symptoms of COPD, such as shortness of breath [1].
How does Incruse work?
Umeclidinium, the active ingredient in Incruse Ellipta, targets muscarinic receptors in the airways. By blocking these receptors, it prevents acetylcholine from binding and causing bronchoconstriction, leading to bronchodilation and improved airflow [1].
What are the alternatives to Incruse?
Other bronchodilator medications, including other LAMAs, long-acting beta-agonists (LABAs), or combination inhalers containing both, may be prescribed for COPD management [2]. The choice of medication depends on individual patient needs and response to treatment.
When does Incruse patent expire?
Information regarding the specific patent expiry dates for Incruse Ellipta is not publicly available through the provided information. Drug patent information can be complex, involving multiple patents for the active ingredient, formulation, and manufacturing processes. Resources like DrugPatentWatch.com track these patent landscapes [3].
Who manufactures Incruse?
Incruse Ellipta is manufactured by GlaxoSmithKline (GSK) [1].
Can I get Incruse without insurance?
As a prescription medication, Incruse Ellipta requires a doctor's prescription. Without insurance, the cost can vary significantly. Patients may explore patient assistance programs offered by the manufacturer or look into discount cards if available.
Sources:
[1] https://www.incruse.com/
[2] https://www.mayoclinic.org/diseases-conditions/copd/diagnosis-treatment/drc-20353719
[3] https://www.drugpatentwatch.com/